| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |